Pycnogenol reduced symptoms in Parkinson’s

Parkinson’s disease (PD) affects nerve cells in the brain that control movement, memory, and thinking. Normally, these cells produce dopamine, a chemical messenger that sends movement signals to the body. PD impairs these cells, reducing dopamine. In this study, 43 people with mild, slow-progressing PD for at least one year continued to take the standard PD treatments carbidopa-levodopa, with or without 150 mg of Pycnogenol® per day. After four weeks, those in the Pycnogenol group had significantly better motor control of body movements, more stable posture, and improved cognitive function compared to those not taking Pycnogenol. A common symptom in the group was fluid retention and swelling in the extremities, called edema. By the end of the study, 14 percent of those not taking Pycnogenol were free from edema compared to 81 percent of those taking Pycnogenol.

Reference: Journal of Neurosurgical Sciences; January, 2020, Published Online

Click To Buy

NOW Foods Pycnogenol